Season 2

S2, E6: iOmx and shaking up the immuno-oncology field with CEO Apollon Papadimitriou, Professor Phillip Beckhove (RCI) and Jared Holz (Mizuho)
Raising BiotechJune 18, 202400:33:23

S2, E6: iOmx and shaking up the immuno-oncology field with CEO Apollon Papadimitriou, Professor Phillip Beckhove (RCI) and Jared Holz (Mizuho)

In this episode of Raising Biotech, Surani finally delves into the scary zone of cancer with German biotech iOmx. The company has raised a total of EUR 115 million (Series A and B) since its inception...

S2, E5: Cerevance and a new approach to Parkinson's disease with CEO Craig Thompson and CNS expert Prof Karl Kieburtz (URMC, Clintrex)
Raising BiotechJune 11, 202400:32:56

S2, E5: Cerevance and a new approach to Parkinson's disease with CEO Craig Thompson and CNS expert Prof Karl Kieburtz (URMC, Clintrex)

In this episode of Raising Biotech, Surani delves into the world of CNS and Parkinson's disease with Cerevance. CEO Craig Thompson joins the podcast to speak about Cerevance's unique mission and use o...

S2, E3: Ray Therapeutics leveraging optogenetics to tackle vision loss with CEO Paul Bresge and Dr José-Alain Sahel (University of Pittsburgh)
Raising BiotechMay 28, 202400:33:51

S2, E3: Ray Therapeutics leveraging optogenetics to tackle vision loss with CEO Paul Bresge and Dr José-Alain Sahel (University of Pittsburgh)

In this episode of Raising Biotech, Surani explores the fascinating world of vision restoration and optogenetics with Ray Therapeutics. The company raised an oversubscribed $100m Series A in May 2023,...

S2, E2: Fauna Bio tapping animal evolution and AI for drug development with CEO Ashley Zehnder and Prof Elinor Karlsson, Broad Institute (MIT/Harvard)
Raising BiotechMay 21, 202400:33:50

S2, E2: Fauna Bio tapping animal evolution and AI for drug development with CEO Ashley Zehnder and Prof Elinor Karlsson, Broad Institute (MIT/Harvard)

In this episode of Raising Biotech, Surani explores the truly unique story of Fauna Bio -- a female trio founding team that is studying evolution and the intersection of animal and human genomics to u...

S2, E1: Mana.bio and programmable lipid nanoparticles with CEO Yogev Debbi and RNA expert Dr Barry Ticho
Raising BiotechMay 14, 202400:33:35

S2, E1: Mana.bio and programmable lipid nanoparticles with CEO Yogev Debbi and RNA expert Dr Barry Ticho

In this episode of Raising Biotech, Surani explores the multi-layered start-up story of Israeli lipid nanoparticle biotech Mana.bio. This is a tech meets biotech story, where AI and machine learning i...